Main MOA brimonidine in glaucoma ?: (A) Decreased aqueous secretion, (B) Increased trabecular outflow, (C) Increased uveoscleral outflow, (D) Reduce vitreous volume
Answer is A. Ans. is 'a' i.e., Decreased aqueous secretion